Cool Cargo Center established at the apron of Incheon International Airport Terminal 2. It is jointly invested and operated by Korean Air and Incheon Airport Corporation. <Photo by Korean Air>

Cool Cargo Center established at the apron of Incheon International Airport Terminal 2. It is jointly invested and operated by Korean Air and Incheon Airport Corporation.

View original image


[Asia Economy Reporter Choi Dae-yeol] Korean Air announced on the 24th that it has renewed its CEIV Pharma certification for pharmaceutical air transport from the International Air Transport Association (IATA). This certification recognizes expertise in the air transport of temperature-sensitive pharmaceuticals, and Korean Air has passed the recertification audit every three years since first receiving the certification in 2019.


To obtain the certification, over 280 items including pharmaceutical transport procedures, storage facilities, equipment, and regulations set by global transport experts must be audited. Korean Air formed a temporary team in February this year to prepare for the certification renewal over five months and passed the audit by IATA specialists.


To transport pharmaceuticals such as vaccines, experimental reagents, and serums, as well as fresh cargo like flowers, seafood, and fruits, it is essential to maintain the optimal temperature required for each item throughout the entire transport process and ensure safe delivery. Korean Air, together with Incheon International Airport Corporation, has minimized external exposure of air cargo by constructing a Cool Cargo Center at the apron of Terminal 2 since September last year.


Korean Air Cargo Plane <Photo by Korean Air>

Korean Air Cargo Plane

View original image


The company stated that thanks to its expertise in transporting special cargo, it was able to contribute to the urgent transport of quarantine supplies during the COVID-19 situation. Korean Air formed a vaccine task force in September 2020 and has been closely cooperating with quarantine authorities to transport COVID-19 vaccines. To date, it has transported over 100 million doses of COVID vaccines and is also shipping treatments and diagnostic kits worldwide.



The company said, "We expect to further strengthen our competitive edge in the international air cargo market by proving our expertise and service quality in pharmaceutical transport in the global market."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing